Buy Strides Pharma Science, target price Rs 630: Prabhudas Lilladher

Prabhudas Lilladher has buy call on Strides Pharma Science with a target price of Rs 630. The current market price of Strides Pharma Science is Rs 541.55.

Strides Pharma Science Ltd., incorporated in the year 1990, is a Mid Cap company (having a market cap of Rs 4874.54 Crore) operating in Pharmaceuticals sector.

Strides Pharma Science Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue, Sale of services and Royalty Income for the year ending 31-Mar-2022.



Financials
For the quarter ended 30-09-2023, the company reported a Consolidated Total Income of Rs 1035.28 Crore, up 10.30 % from last quarter Total Income of Rs 938.64 Crore and up 12.46 % from last year same quarter Total Income of Rs 920.56 Crore. Company reported net profit after tax of Rs -107.20 Crore in latest quarter.


Promoter/FII Holdings
Promoters held 28.07 per cent stake in the company as of 30-Jun-2023, while FIIs owned 16.72 per cent, DIIs 19.59 per cent.